Umbralisib is a drug used to treat Chronic Lymphocytic Leukemia, Follicular Lymphoma, Small Lymphocytic Lymphoma, and other conditions. Umbralisib is being actively studied in 19 studies and prior, has been studied in 1.
|Top Sponsors||Top Sites||Top Investigators|
|TG Therapeutics, Inc.||TG Therapeutics Investigational Trial Site||Amitkumar Mehta, MD|
|City of Hope Medical Center||City of Hope Medical Center||Jacob Soumerai, MD|
|ADC Therapeutics S.A.||Ohio State University Comprehensive Cancer Center||Jennifer R. Brown, MD, PhD|